このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Narayana Hrudayalaya 将来の成長

Future 基準チェック /36

Narayana Hrudayalaya利益と収益がそれぞれ年間9.8%と12.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に22.6% 9.6%なると予測されています。

主要情報

9.8%

収益成長率

9.6%

EPS成長率

Healthcare 収益成長	25.8%
収益成長率	12.4%
将来の株主資本利益率	23.0%
アナリストカバレッジ	Good
最終更新日	11 Jul 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BSE:539551 - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	73,194	11,053	7,814	15,016	3
3/31/2026	65,298	9,035	4,174	13,014	9
3/31/2025	57,603	7,895	-1,859	11,738	9
3/31/2024	50,182	7,893	960	10,666	N/A
12/31/2023	49,688	7,717	N/A	N/A	N/A
9/30/2023	48,933	7,375	5,102	10,323	N/A
6/30/2023	47,297	6,796	N/A	N/A	N/A
3/31/2023	45,297	6,062	5,625	10,846	N/A
12/31/2022	42,439	5,020	N/A	N/A	N/A
9/30/2022	40,755	4,457	5,587	8,093	N/A
6/30/2022	38,746	3,763	N/A	N/A	N/A
3/31/2022	37,013	3,419	2,343	4,850	N/A
12/31/2021	36,047	3,410	N/A	N/A	N/A
9/30/2021	33,954	2,843	4,082	4,783	N/A
6/30/2021	30,559	1,816	N/A	N/A	N/A
3/31/2021	25,839	-143	2,342	3,043	N/A
12/31/2020	25,049	-704	N/A	N/A	N/A
9/30/2020	25,397	-798	1,988	3,147	N/A
6/30/2020	27,677	-310	N/A	N/A	N/A
3/31/2020	31,365	1,189	3,275	4,433	N/A
12/31/2019	31,705	1,441	N/A	N/A	N/A
9/30/2019	31,152	1,254	2,191	3,691	N/A
6/30/2019	30,009	936	N/A	N/A	N/A
3/31/2019	28,740	592	1,286	2,786	N/A
12/31/2018	27,507	318	N/A	N/A	N/A
9/30/2018	25,728	332	N/A	N/A	N/A
6/30/2018	24,233	362	N/A	N/A	N/A
3/31/2018	22,943	513	-215	1,823	N/A
12/31/2017	21,243	639	N/A	N/A	N/A
9/30/2017	20,259	668	N/A	N/A	N/A
6/30/2017	19,494	767	N/A	N/A	N/A
3/31/2017	18,884	831	N/A	2,194	N/A
12/31/2016	18,220	637	N/A	N/A	N/A
9/30/2016	17,553	525	N/A	N/A	N/A
6/30/2016	16,868	364	N/A	N/A	N/A
3/31/2016	16,176	212	N/A	1,741	N/A
12/31/2015	15,471	219	N/A	N/A	N/A
3/31/2015	13,683	-168	N/A	767	N/A
3/31/2014	10,983	317	N/A	1,100	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 539551の予測収益成長率 (年間9.8% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: 539551の収益 ( 9.8% ) Indian市場 ( 15.9% ) よりも低い成長が予測されています。

高成長収益: 539551の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 539551の収益 ( 12.4% ) Indian市場 ( 9.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: 539551の収益 ( 12.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 539551の自己資本利益率は、3年後には高くなると予測されています ( 22.6 %)

Narayana Hrudayalaya 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Price target increased by 8.1% to ₹1,390

Price target increased by 7.3% to ₹1,192

Price target increased by 8.2% to ₹1,070

Price target increased by 7.5% to ₹943

Price target increased by 7.4% to ₹878

Price target increased to ₹707

Recent updates

New minor risk - Dividend sustainability

Full year 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited Recommends Final Dividend for the Year Ended 31St March, 2024

Narayana Hrudayalaya Limited to Report Q4, 2024 Results on May 24, 2024

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

Price target increased by 7.3% to ₹1,192

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.2% to ₹1,070

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹2.50 per share at 0.3% yield

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Insufficient new directors

Price target increased to ₹707

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS ₹4.89 (vs ₹0.17 loss in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹5.90 loss in 1Q 2021)

Additional Non-Executive & Independent Director Nivruti Rai has left the company

Full year 2021 earnings released: ₹0.70 loss per share (vs ₹5.86 profit in FY 2020)

Price target increased to ₹525

Narayana Hrudayalaya Limited to Report Q3, 2021 Results on Feb 05, 2021

Narayana Hrudayalaya Limited Announces Resignation of Manohar Dayaram Chatlani from the Position of Independent Director

Narayana Hrudayalaya Limited Announces Discontinuation of Operation and Sale of Heart Centre in Durgapur, West Bengal

New 90-day high: ₹450

Price target raised to ₹393

New 90-day high: ₹386

New 90-day high: ₹367

Narayana Health in India Joins the Trinetx Network to Drive Innovation and Attract Global Clinical Trials

Second quarter 2021 earnings released: ₹0.17 loss per share

Revenue beats expectations, earnings disappoint

New 90-day high: ₹347

Narayana Hrudayalaya Limited to Report Q1, 2021 Results on Aug 04, 2020

First quarter earnings released

New 90-day high - ₹302

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘